信达生物(01801)授出9.18万份购股权及13.74万股受限制股份
信达生物(01801)发布公告,于2023年12月7日,公司根据首次公开发售后雇员持股计划的条款向5名承授人授出9.18万份购股权,惟须待承授人接纳。所有承授人均为公司雇员。所授出购股权的行使价为每股股份42.84港元。
此外,于2023年12月7日,公司根据2020年受限制股份计划的条款向5名承授人(为公司非关连雇员)授出13.74万股受限制股份,惟须待接纳及达成绩效目标,方可作实。
Reprinted from 引领外汇网,the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.